StockData
Ionis Pharmaceuticals Inc logo

Ionis Pharmaceuticals Inc (IONS) stock

IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/303% below fair value
$27.39+0.43 (+1.59%)

Close on Nov 18, 2026Market cap $4.55BP/E –Yield –

Ionis Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Ionis Pharmaceuticals's market cap was $4.69B on Nov 11, 2026, against $13.33B a year earlier. Over the last 5 years it ranged from $4.30B to $13.33B, with a median of $6.03B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.69B-63.2%
2025Dec 31, 2025$12.75B+131.1%
2024Dec 31, 2024$5.52B-23.9%
2023Dec 29, 2023$7.25B+35.2%
2022Dec 30, 2022$5.36B+24.9%
2021Dec 31, 2021$4.30B-45.6%
2020Dec 31, 2020$7.90B-7.0%
2019Dec 31, 2019$8.50B+14.3%
2018Dec 31, 2018$7.43B+18.6%
2017Dec 29, 2017$6.27B+8.2%
2016Dec 30, 2016$5.79B-22.0%
2015Dec 31, 2015$7.43B+2.0%
2014Dec 31, 2014$7.28B+57.6%
2013Dec 31, 2013$4.62B+337.4%
2012Dec 31, 2012$1.06B+46.9%
2011Dec 30, 2011$719.01M-28.4%
2010Dec 31, 2010$1.00B-4.4%
2009Dec 31, 2009$1.05B–

More Ionis Pharmaceuticals figures

See a number that looks wrong?